tirzepatide acetate 40mg — 40mg/vial Reference Standard Tirzepatide (Mounjaro) In Sherman Oaks

Tirzepatide works as a dual GLP-1 and GIP receptor agonist, enhancing appetite suppression, improving insulin sensitivity, and promoting earlier satiety

SURMOUNT-1 trial

This article examines the evidence, explores alternative management options compatible with breastfeeding, and clarifies when to seek medical advice to ensure both maternal and infant wellbeing

******3rd party tracking services, like Google Analytics, Google Tag manager, Facebook, Instagram, Meta Pixels track, collect and use IP address and other data and location data about patient PHI

Some protocols use up to 1,000 mg per day under medical supervision

We offer a variety of medications to support your weight loss